Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00046930
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2002-10-03
Brief Title:
Daunorubicin Cytarabine - Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
CDR0000257122
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eastern Cooperative Oncology Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Kanisa Pharmaceuticals | INDUSTRY |
| National Cancer Institute NCI | NIH |
| Eli Lilly and Company | INDUSTRY |